HRMY: Harmony Biosciences Holdings, Inc. Stock

by  •  • Comments Off on HRMY: Harmony Biosciences Holdings, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,754.87
Enterprise Value ($M) 1,611.88
Book Value ($M) 515.39
Book Value / Share 9.08
Price / Book 3.40
NCAV ($M) 147.91
NCAV / Share 2.60
Price / NCAV 11.86

Profitability (mra)
Return on Invested Capital (ROIC) 0.19
Return on Assets (ROA) 0.19
Return on Equity (ROE) 0.31

Liquidity (mrq)
Quick Ratio 3.07
Current Ratio 3.11

Balance Sheet (mrq) ($M)
Current Assets 479.50
Assets 846.99
Liabilities 331.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 582.02
Operating Income 192.03
Net Income 128.85

Cash Flow Statement (mra) ($M)
Cash From Operations 219.39
Cash from Investing -46.44
Cash from Financing -105.55

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Valor IV Pharma Holdings, LLC 19.20 0.10
02-13 13G/A Vanguard Group Inc 6.27 12.91
02-09 13G/A Fmr Llc 9.01 -5.48
01-24 13G/A BlackRock Inc. 10.20 -2.11

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-30 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-02-28 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A (Amendment No.1)
2024-02-22 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-10-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-07 34,934 190,967 18.29
2024-05-06 66,324 131,774 50.33
2024-05-03 136,439 546,130 24.98
2024-05-02 142,492 263,410 54.10

(click for more detail)

Similar Companies
GLYC – GlycoMimetics, Inc. GRTX – Galera Therapeutics, Inc.
HCWB – HCW Biologics Inc. HROW – Harrow, Inc.
IKNA – Ikena Oncology, Inc.


Financial data and stock pages provided by
Fintel.io